Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Oct 18;15(23):3278–3295. doi: 10.1080/15384101.2016.1243189

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Taylor & Francis

PMC Copyright notice

Figure 8. — Meta-analysis of CCNG2 expression in breast cancer (BC) tumor types and its correlation with relapse free (RFS) and distant metastasis free (DMFS) survival in breast cancer patients. (A, B) Box-plots assessing CCNG2 expression in BC subtype (A) or grade classified BC tumor tissues (B) from all or tamoxifen-treated (B, right) patients (numbers of sample size at top of box-plot panels). (C, D) Kaplan-Meier survival curves estimating probability of survival for patients with tumors expressing high or low levels of CCNG2 (stratified on basis of tumor characteristics and therapy). HR = Hazard ratio. Data were assembled from online microarray databases and analyzed using the GOBO - Gene expression-based Outcome for Breast cancer Online software (http://co.bmc.lu.se/gobo) and the KM plotter tool for breast cancer (http://kmplot.com/analysis/). PR = progesterone receptor, LN = lymph node.